INS and metabolic dysfunction-associated steatotic liver disease: Since NAFLD is often associated with insulin resistance, even though in a complex and bidirectional relationship, drugs increasing insulin sensitivity have been proposed to treat liver steatosis and prevent diabetes in these patients.